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Oxygen therapy in palliative care 
Abstract 
Breathlessness in advanced disease is a common problem, with the majority of people experiencing 
breathlessness in the weeks before death. The thrust of the new British Thoracic Society guidelines for 
home oxygen in adults is that oxygen therapy for home use is most useful in chronic hypoxaemia. 
However, clinicians make individual clinical decisions, cognisant of the guidelines but ultimately 
determined by what relieves the symptoms of the individual most effectively. 
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PERSPECTIVE OPEN
Oxygen therapy in palliative care
H John Fardy1
Breathlessness in advanced disease is a common problem, with the majority of people experiencing breathlessness in the weeks
before death. The thrust of the new British Thoracic Society guidelines for home oxygen in adults is that oxygen therapy for home
use is most useful in chronic hypoxaemia. However, clinicians make individual clinical decisions, cognisant of the guidelines but
ultimately determined by what relieves the symptoms of the individual most effectively.
npj Primary Care Respiratory Medicine (2016) 26, 15073; doi:10.1038/npjpcrm.2015.73; published online 7 January 2016
The recent publication of the article ‘When should I be considering
home oxygen for my patients’ is timely.1 On the basis of the new
British Thoracic Society guidelines for home oxygen in adults,2 it is
a practical summary and the explanation of when to use oxygen
therapy by means of developing case studies is helpful.
Oxygen is a therapy and, as a result, has benefits, but also risks.
We are all aware of the ‘carbon dioxide retainer’ in chronic
obstructive pulmonary disease (COPD), but there are also other
situations in which oxygen therapy has risks. It is a drug that must
be dosed and monitored appropriately.
The thrust of the guideline is that oxygen therapy for home use
is most useful in chronic hypoxaemia. If the person is breathless,
but not hypoxic, oxygen is generally not indicated. Alternative
ways of dealing with breathlessness include the moving of air
across the dermatomes of the trigeminal nerve (‘fan therapy’).
Oral morphine in low doses (the dose is much less than for pain) is
the drug of choice for breathlessness.
Breathlessness in advanced disease is a common problem
(see Table 1),3 with 65% of people experiencing breathlessness in
the weeks before death.4 Particularly in the palliative care setting,
many patients have multimorbidity and sometimes the breath-
lessness is unrelated to their palliative care problem. A patient
who has a malignancy may also have heart failure, anaemia,
recent-onset pleural effusion, hypothyroid disease or undiagnosed
and therefore untreated COPD. All these diagnoses can present as
breathlessness. In addition, having dyspnoea is anxiety-provoking
and being anxious can provoke dyspnoea. The strategy of
(i) adequate history, (ii) appropriate examination, (iii) consideration
of this patient’s problem and finally (iv) consideration of special
investigations will hopefully lead to a diagnosis.
Guidelines make absolute recommendations. If a patient with
advanced disease is breathless and hypoxic, oxygen is the
preferred treatment; if they are breathless and not hypoxic,
oxygen is not recommended. However, clinicians will (and should)
make individual clinical decisions, cognisant of the guidelines but
ultimately determined by what relieves the symptoms of the
individual most effectively. The art of medicine lies in deciding,
with the patient, what is reasonable treatment for this patient at
this time.
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Table 1. Prevalence of breathlessness in advanced disease3








Chronic kidney disease 11–62%
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